share_log

Nautilus Biotechnology Q3 EPS $(0.13) Beats $(0.17) Estimate

Benzinga ·  Oct 31, 2023 07:17

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 18.18 percent decrease over losses of $(0.11) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment